The GCCP scorecard will illustrate how selected companies are performing on the 18 selected good practices. There are 18 good practices that pharmaceutical developers/manufacturers of Covid-19 vaccines & therapeutics should undertake to align their actions with human rights principles and international standards for equitable access to medicines.
Tag: GCCP Score card
EVENT: Discussing pharmaceutical human rights accountability during Covid-19
FtV Projectcoordinator -
An International Expert Panel Discussion on Good Covid-19 Company Practices (GCCP)
The Pharmaceutical Accountability Foundation is organising an event on its Good Covid-19 Company Practices...
The Pharmaceutical Accountability Foundation scores pharmaceutical companies’ behaviour regarding Covid-19 in a GCCP Scorecard. Conclusion: Big differences in adherence to human rights principles
Farma ter Verantwoording -
Bergeijk, 22 January 2021 – Pharmaceutical Accountability Foundation (PAF) publishes a GCCP scorecard of pharmaceutical companies that develop important vaccines and pharmaceuticals for the...
Licensed under Creative Commons (CC BY-NC-SA 4.0), The Pharmaceutical Accountability Foundation 2022